Cite

HARVARD Citation

    Xu, J. et al. (2017). Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus. Bioorganic & medicinal chemistry letters. 27 (9), pp. 2069-2073. [Online]. 
  
Back to record